Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Observer-blinded Non Inferiority Trial to Evaluate the Immunogenicity and Safety of Locally Manufactured Hepatitis B Vaccine 'Hepa B' in Bangladeshi Healthy Adults.

NCT03627507 is registered in ClinicalTrials.gov with International Centre for Diarrhoeal Disease Research, Bangladesh as lead sponsor.

NCT NCT03627507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03627507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Observer-blinded Non Inferiority Trial to Evaluate the Immunogenicity and Safety of Locally Manufactured Hepatitis B Vaccine 'Hepa B' in Bangladeshi Healthy Adults.
Lead sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh
Phase
Phase 2/3
Overall status
Completed
Start date
July 29, 2018
Completion date
June 3, 2019
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b infection